Difficulty: Medium
Average Score: 86%
Practice
This drug has beta-adrenergic blocking activity:
Correct answer
B
Rationale
The correct answer is B) Sotalol because it is a non-selective beta-adrenergic blocking agent used for its antiarrhythmic properties. Sotalol works by blocking beta-adrenergic receptors in the heart, leading to a decrease in heart rate and contractility. This helps in managing various cardiac conditions like atrial fibrillation and ventricular arrhythmias.
Now, let's analyze why the other options are incorrect:
A) Flecainide is a class Ic antiarrhythmic drug that works by blocking sodium channels in the heart to decrease conduction velocity. It does not have beta-adrenergic blocking activity.
C) Lidocaine is a local anesthetic and antiarrhythmic medication that works by blocking sodium channels, primarily used for ventricular arrhythmias. It does not have beta-adrenergic blocking activity.
D) Verapamil is a calcium channel blocker that primarily acts on the calcium channels in the heart and blood vessels to lower blood pressure and control heart rate. It does not have beta-adrenergic blocking activity.
Educational Context:
Understanding the pharmacological properties of various drugs is crucial for healthcare professionals to make informed decisions regarding drug therapy. Knowing which drugs have beta-adrenergic blocking activity is essential in managing conditions like hypertension, angina, arrhythmias, and heart failure. It helps in selecting the most appropriate medication based on the patient's condition and individual characteristics.
Now, let's analyze why the other options are incorrect:
A) Flecainide is a class Ic antiarrhythmic drug that works by blocking sodium channels in the heart to decrease conduction velocity. It does not have beta-adrenergic blocking activity.
C) Lidocaine is a local anesthetic and antiarrhythmic medication that works by blocking sodium channels, primarily used for ventricular arrhythmias. It does not have beta-adrenergic blocking activity.
D) Verapamil is a calcium channel blocker that primarily acts on the calcium channels in the heart and blood vessels to lower blood pressure and control heart rate. It does not have beta-adrenergic blocking activity.
Educational Context:
Understanding the pharmacological properties of various drugs is crucial for healthcare professionals to make informed decisions regarding drug therapy. Knowing which drugs have beta-adrenergic blocking activity is essential in managing conditions like hypertension, angina, arrhythmias, and heart failure. It helps in selecting the most appropriate medication based on the patient's condition and individual characteristics.